Skip to main content
editorial
. 2016 Oct 5;2(4):219–226.

Table 1.

Animals Duration of infection (days) Sample Virus Duration on ART (days) Viral load (RNA copies/mL) ART regimen
RM1 10 PBMC SHIVSF162p3 n/a 3.80E+05 n/a
126 PBMC SHIVSF162p3 n/a 2.11E+05 n/a
RM2 14 PBMC SHIVSF162p3 n/a 3.78E+05 n/a
84 PBMC SHIVSF162p3 n/a 7.80E+04 n/a
RM3 14 PBMC SHIVSF162p3 n/a 9.20E+07 n/a
364 PBMC SHIVSF162p3 n/a 6.21E+05 n/a
RM4 14 PBMC SHIVSF162p3 n/a 3.76E+07 n/a
84 PBMC SHIVSF162p3 n/a 1.83E+05 n/a
RM5 21 PBMC SHIVSF162p3 n/a 1.54E+06 n/a
84 PBMC SHIVSF162p3 n/a 4.41E+02 n/a
RM6 14 PBMC SHIVSF162p3 n/a 4.85E+06 n/a
126 PBMC SHIVSF162p3 n/a 9.47E+05 n/a
RM7 14 PBMC SHIVSF162p3 n/a 1.63E+06 n/a
84 PBMC SHIVSF162p3 n/a 5.20E+03 n/a
RM8 14 PBMC SHIVSF162p3 n/a 5.37E+06 n/a
126 PBMC SHIVSF162p3 n/a 1.37E+05 n/a
RM9 14 PBMC SHIVSF162p3 n/a 1.55E+06 n/a
210 PBMC SHIVSF162p3 n/a 2.99E+05 n/a
RM10 14 PBMC SHIVSF162p3 n/a 6.62E+05 n/a
308 PBMC SHIVSF162p3 n/a 1.00E+02 n/a
RM13 473 ileac LN SIVmac251 421 <60 PMPA-FTC-RAL-DRV/r-MVC
RM14 456 ileac LN SIVmac251 404 <60 PMPA-FTC-RAL-DRV/r-MVC
456 colonic LN SIVmac251 404 <60 PMPA-FTC-RAL-DRV/r-MVC
RM15 477 ileac lLN SIVmac251 425 <60 PMPA-FTC-RAL-DRV/r-MVC
477 colonic LN SIVmac251 425 <60 PMPA-FTC-RAL-DRV/r-MVC
RM16 241 superficial LN SIVmac251 183 <60 PMPA-FTC-RAL-DRV/r
241 spleen SIVmac251 183 <60 PMPA-FTC-RAL-DRV/r
RM17 261 mesenteric LN SIVmac251 203 <60 PMPA-FTC-RAL-DRV/r
261 spleen SIVmac251 203 <60 PMPA-FTC-RAL-DRV/r
RM18 210 PBMC SIVmac251 144 <60 PMPA-FTC-ZDV-LPV/r
RM19 210 PBMC SIVmac251 144 <60 PMPA-FTC-ZDV-LPV/r
RM20 210 PBMC SIVmac251 144 7.59E+02 PMPA-FTC-ZDV-LPV/r
RM21 210 PBMC SIVmac251 140 <60 PMPA-FTC-ZDV-LPV/r
RM22 210 PBMC SIVmac251 140 1.07E+02 PMPA-FTC-ZDV-LPV/r
RM23 210 PBMC SIVmac251 144 <60 PMPA-FTC-ZDV-LPV/r
RM24 210 PBMC SIVmac251 140 <60 PMPA-FTC-ZDV-LPV/r
RM25 210 PBMC SIVmac251 144 <60 PMPA-FTC-ZDV-LPV/r

PMPA: tenofovir; FTC: emtricitabine; RAL: raltegravir; DRV/r: darunavir/ritonavir; MVC: maraviroc; LPV/r: lopinavir/ritonavir; ZDV: zidovudine.